STOCK TITAN
  1. Home
  2. News
  3. APLIF

Appili Therapeutics Inc - APLIF STOCK NEWS

IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Announces Results of Annual Meeting of Shareholders and Provides Corporate Update
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Presents at the 10th International Tularemia Conference
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Announces U.S. FDA Approval of LIKMEZ™ (ATI-1501) Metronidazole Oral Suspension
fda approval
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2024
earnings
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Announces Bridge Loan from Bloom Burton & Co.
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics – Press Release Correction
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Reports Fiscal Year 2023 Financial and Operational Results
earnings
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Announces Issuance of Patent for ATI-1501 Liquid Oral Reformulation of Metronidazole
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics Secures Contract for ATI-1701 Funding from the U.S. Air Force Academy
IMPACT
SENTIMENT
APLIF : OTC
Appili Therapeutics to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference
conferences
Stock APLIF logo
Appili Therapeutics Inc
OTC:APLIF

APLIF Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing